Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The closing price of Ingevity Corp (NYSE: NGVT) was $46.2 for the day, down -15.17% from the previous closing price of $54.46. In other words, the price has decreased by -$15.17 from its previous closing price. On the day, 0.56 million shares were traded. NGVT stock price reached its highest trading level at $56.0909 during the session, while it also had its lowest trading level at $45.87.
Ratios:
Our analysis of NGVT’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 20.20 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.03. For the most recent quarter (mrq), Quick Ratio is recorded 0.80 and its Current Ratio is at 1.27. In the meantime, Its Debt-to-Equity ratio is 9.13 whereas as Long-Term Debt/Eq ratio is at 8.39.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for the company, BMO Capital Markets on February 26, 2025, Upgraded its rating to Outperform and sets its target price to $65 from $62 previously.
On August 07, 2024, CJS Securities Upgraded its rating to Market Outperform which previously was Market Perform but kept the price unchanged to $58.
Jefferies Upgraded its Hold to Buy on April 22, 2024, whereas the target price for the stock was revised from $52 to $62.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 11 ’25 when STUART EDWARD WOODCOCK JR. bought 3,700 shares for $52.61 per share.
STUART EDWARD WOODCOCK bought 6,720 shares of NGVT for $323,904 on Aug 05 ’25.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NGVT now has a Market Capitalization of 1684742400 and an Enterprise Value of 3284753920. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.32 while its Price-to-Book (P/B) ratio in mrq is 13.96. Its current Enterprise Value per Revenue stands at 2.479 whereas that against EBITDA is 8.362.
Stock Price History:
The Beta on a monthly basis for NGVT is 1.39, which has changed by 0.20380199 over the last 52 weeks, in comparison to a change of 0.13355756 over the same period for the S&P500. Over the past 52 weeks, NGVT has reached a high of $60.77, while it has fallen to a 52-week low of $28.49. The 50-Day Moving Average of the stock is -17.17%, while the 200-Day Moving Average is calculated to be -0.67%.
Shares Statistics:
NGVT traded an average of 240.36K shares per day over the past three months and 207540 shares per day over the past ten days. A total of 36.47M shares are outstanding, with a floating share count of 35.93M. Insiders hold about 1.48% of the company’s shares, while institutions hold 98.71% stake in the company. Shares short for NGVT as of 1760486400 were 929966 with a Short Ratio of 3.87, compared to 1757894400 on 828233. Therefore, it implies a Short% of Shares Outstanding of 929966 and a Short% of Float of 3.5700000000000003.
Earnings Estimates
. The current rating of Ingevity Corp (NGVT) is the result of assessments by 3.0 analysts actively engaged in evaluating its market dynamics.The consensus estimate for the next quarter is $0.9, with high estimates of $0.9 and low estimates of $0.89.
Analysts are recommending an EPS of between $4.99 and $4.7 for the fiscal current year, implying an average EPS of $4.84. EPS for the following year is $5.09, with 4.0 analysts recommending between $5.82 and $4.35.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 2 analysts. It ranges from a high estimate of $302M to a low estimate of $281M. As of. The current estimate, Ingevity Corp’s year-ago sales were $298.8MFor the next quarter, 2 analysts are estimating revenue of $285.67M. There is a high estimate of $305M for the next quarter, whereas the lowest estimate is $256M.
A total of 3 analysts have provided revenue estimates for NGVT’s current fiscal year. The highest revenue estimate was $1.34B, while the lowest revenue estimate was $1.25B, resulting in an average revenue estimate of $1.29B. In the same quarter a year ago, actual revenue was $1.41BBased on 4 analysts’ estimates, the company’s revenue will be $1.31B in the next fiscal year. The high estimate is $1.38B and the low estimate is $1.2B.
